The Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation

NCT03489135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2021-05-21

No results posted yet for this study

Summary

This is an open label, prospective, non-randomised, multi-centre first-in-human evaluation of the Vetex Thrombectomy Device for treatment of acute iliofemoral deep vein thrombosis (DVT)

Conditions

  • Deep Vein Thrombosis Leg

Interventions

DEVICE

ReVene Thrombectomy Catheter

Endovascular treatment of an acute iliofemoral DVT

Sponsors & Collaborators

  • Vetex Medical Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-13
Primary Completion
2020-03-03
Completion
2021-05-07

Countries

  • Bulgaria
  • Germany
  • Ireland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03489135 on ClinicalTrials.gov